Multi-omics aging clocks integrate epigenetic, transcriptomic, proteomic, metabolic, and microbial data to quantify biological age with greater accuracy than single-omics models, offering improved risk stratification for preventive medicine. The critical gap lies not in measurement precision but in distinguishing pathological damage from adaptive remodeling—a distinction that determines which interventions will meaningfully slow aging.
Key Points
- Multi-omics integration captures biological heterogeneity single-omics models miss
- Distinguishing damage from adaptive remodeling is most actionable target
- Validation gaps and timescale mismatches remain unresolved challenges
Longevity Analysis
The capacity to measure biological age across multiple data layers represents a fundamental shift from guessing at intervention efficacy to quantifying actual aging trajectory. However, measurement accuracy without biological interpretation creates a false sense of progress. The real work ahead involves understanding whether detected changes reflect accumulating damage—which responds to intervention—or necessary adaptation to environmental stress. This distinction directly shapes which protocols actually extend healthspan versus which merely alter markers. Practitioners need clocks that decode what the body's signals mean before selecting interventions, not clocks that simply generate more precise numbers.
Original published by Wiley Aging Cell, by Liying Liu, Yuanyuan Lai, Chunhui Tian, Yufei Huang, Jianheng Hao, Yuemeng Zhao, Dan Chen, Tianyu Wu, Daqian Zhou, Xiaoyan Zheng, Han Yang, Zheng Yu, Nihong Li, Jie Yang .